Literature DB >> 11894929

Comparison of the binding sites for the Escherichia coli cAMP receptor protein at the lactose and galactose promoters.

A Kolb1, S Busby, M Herbert, D Kotlarz, H Buc.   

Abstract

Polyacrylamide gel electrophoresis has been used to visualise and quantitate complexes between the Escherichia coli cyclic AMP receptor protein (CRP) and DNA fragments containing the promoter region of either the E. coli galactose or lactose operons. We show that, although CRP binding to the gal fragment is weaker than binding to the lac fragment, in each case, stable complexes are formed between one dimer of CRP and one molecule of DNA. We have examined the effects of a series of deletions and point mutations in the gal promoter region on CRP binding. From the position of deletions and mutations which prevent the formation of stable complexes, we deduce the location and extent of the sequence at the CRP binding site. We show that it covers approximately the same length of sequence as the binding site at the lac promoter. Unlike the lac site, the gal site contains no palindromic sequence. We discuss the importance of symmetry in the sequence at CRP binding sites and the validity of CRP binding consensus sequences which have been proposed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 11894929      PMCID: PMC555116          DOI: 10.1002/j.1460-2075.1983.tb01408.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  20 in total

1.  Cooperative binding to DNA of catabolite activator protein of Escherichia coli.

Authors:  S A Saxe; A Revzin
Journal:  Biochemistry       Date:  1979-01-23       Impact factor: 3.162

2.  Mechanism of araC autoregulation and the domains of two overlapping promoters, Pc and PBAD, in the L-arabinose regulatory region of Escherichia coli.

Authors:  N L Lee; W O Gielow; R G Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

3.  The Escherichia coli L-arabinose operon: binding sites of the regulatory proteins and a mechanism of positive and negative regulation.

Authors:  S Ogden; D Haggerty; C M Stoner; D Kolodrubetz; R Schleif
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

4.  Interaction site of Escherichia coli cyclic AMP receptor protein on DNA of galactose operon promoters.

Authors:  T Taniguchi; M O'Neill; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  Non-specific interactions of CRP from E. coli with native and denatured DNAs: control of binding by cAMP and cGMP and by cation concentration.

Authors:  M Takahashi; B Blazy; A Baudras
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

6.  Cyclic AMP receptor proteins interacts with lactose operator DNA.

Authors:  A Schmitz
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

7.  Interaction of the cAMP receptor protein with the lac promoter.

Authors:  R B Simpson
Journal:  Nucleic Acids Res       Date:  1980-02-25       Impact factor: 16.971

8.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

9.  Molecuar model of the DNA interaction site for the cyclic AMP receptor protein.

Authors:  M C O'Neill; K Amass; B de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Tandem CRP binding sites in the deo operon of Escherichia coli K-12.

Authors:  P Valentin-Hansen
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  24 in total

1.  NMR study of the structural changes induced in the E. coli lac promoter by the specific binding of the CAP protein.

Authors:  R Schumacher; F Buck; H Rüterjans
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

2.  Interactions between the Escherichia coli cAMP receptor protein and the C-terminal domain of the alpha subunit of RNA polymerase at class I promoters.

Authors:  E C Law; N J Savery; S J Busby
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Probing the sequence-specific interaction of the cyclic AMP receptor protein with DNA by site-directed mutagenesis.

Authors:  M E Gent; A M Gronenborn; R W Davies; G M Clore
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

4.  Binding of the Escherichia coli cyclic AMP receptor protein to DNA fragments containing consensus nucleotide sequences.

Authors:  K Gaston; A Kolb; S Busby
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

5.  Essential and nonessential sequences in malPp, a positively controlled promoter in Escherichia coli.

Authors:  O Raibaud; C Gutierrez; M Schwartz
Journal:  J Bacteriol       Date:  1985-03       Impact factor: 3.490

6.  The binding of the cyclic AMP receptor protein to synthetic DNA sites containing permutations in the consensus sequence TGTGA.

Authors:  C Jansen; A M Gronenborn; G M Clore
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

7.  Lac repressor-Lac operator complexes. Solution X-ray scattering and electrophoretic studies.

Authors:  F Culard; M Charlier; J C Maurizot; A Tardieu
Journal:  Eur Biophys J       Date:  1987       Impact factor: 1.733

8.  Repression and catabolite gene activation in the araBAD operon.

Authors:  H S Lichenstein; E P Hamilton; N Lee
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

9.  Sequence-dependent contribution of distal binding domains to CAP protein-DNA binding affinity.

Authors:  D D Dalma-Weiszhausz; M R Gartenberg; D M Crothers
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

10.  The role of two surface exposed loops in transcription activation by the Escherichia coli CRP and FNR proteins.

Authors:  R Williams; A Bell; G Sims; S Busby
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.